Without an approved Summary of Product Characteristics (SmPC), there is no authoritative basis for specifying diluent type, volume, or reconstitution technique for retatrutide
NICE guidance recommends GLP-1 receptor agonists as treatment options for type 2 diabetes in specific circumstances, typically when other medications have not achieved adequate glycaemic control or when weight loss would provide additional benefit
The typical dosage is 1.75 mg per injection, administered once every 48 hours
Advertisement As Wharton says, theres much more work to be done in obesity medicine to promote understanding of the condition and advance therapies
800 Scudders Mill Road Plainsboro, NJ 08536 1-833-Wegovy-1 WEGOVY is a registered trademark of Novo Nordisk A/S
The regulatory landscape in this space changes frequently